Four-day continuous gastric pH monitoring following anti-acid secretory drug administration: Cross-over test to assess the early effects

Alimentary Pharmacology and Therapeutics

Volumn 27, Issue 1, 2008, Pages 66-71

  Suzuki, T ^a   Yamaguchi, T ^b   Odaka, T ^a   Kobayashi, M ^a   Seza, A ^a   Kouzu, T ^a   Yokosuka, O ^a  

^a CHIBA UNIVERSITY   (Japan)

^b CHIBA CANCER CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIHISTAMINIC AGENT; FAMOTIDINE; LANSOPRAZOLE; PROTON PUMP INHIBITOR;

ADULT; ARTICLE; CROSSOVER PROCEDURE; DRUG EFFECT; DRUG MECHANISM; GASTRIC PH MONITORING; HUMAN; MALE; METHODOLOGY; NORMAL HUMAN; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE; STOMACH ACID SECRETION; VOLUNTEER;

2-PYRIDINYLMETHYLSULFINYLBENZIMIDAZOLES; ADULT; ANTI-ULCER AGENTS; CROSS-OVER STUDIES; FAMOTIDINE; GASTRIC ACID; GASTRIC ACIDITY DETERMINATION; HISTAMINE H2 ANTAGONISTS; HUMANS; MALE; PROTON PUMP INHIBITORS; TIME FACTORS;

EID: 36749063056     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/j.1365-2036.2007.03545.x     Document Type: Article

References (17)

1. Masahiro S, Kiyoshi A, Eiji U, Hirofumi M, Kenichi K. Suppressive action of lansoprazole on gastric acidity and its clinical effect in patients with gastric ulcers: comparison with famotidine. J Clin Gastroenterol 1995 20 (Suppl. 2 S27 31.
2. Masaki I. Effect of H2 receptor antagonist and proton pump inhibitor on 24-hour intragastric pH in fasting patients. Ther Res 1997 18: 291 4.
3. Hiroshi T, Kaku H, Masahiro A. Evaluation of the effect of lansoprazole in suppressing acid secretion using 24-hour intragastric pH monitoring. J Clin Gastroenterol 1995 20 (Suppl. 1 S7 9.
4. Masahiko I, Jun-Ichi T, Tomoyuki I, et al. Early effects of lafutidine or rabeprazole on intragastric acidity: which drug is more suitable for on-demand use? J Gastroenterol 2005 40: 453 8.
5. Bell NJV, Hunt RH. Time to maximum effect of lansoprazole on gastric pH in normal male volunteers. Aliment Pharmacol Ther 1996 10: 897 904.
6. Jorgen W, Folke J, Jan J, et al. Wireless esophageal pH monitoring is better tolerated than the catheter-based technique: results from a randomized cross-over trial. Am J Gastroenterol 2007 102: 239 45.
7. Nagaya H, Satoh H, Maki Y. Possible mechanism for the inhibition of acid formation by the proton pump inhibitor AG-1749 in isolated canine parietal cells. J Pharmacol Exp Ther 1990 252: 1289 95.
8. Hongo M, Ohara S, Hirasawa Y, et al. Effect of lansoprazole on intragastric pH: comparison between morning and evening dose. Dig Dis Sci 1992 37: 882 90.
9. Burget DW, Chiverton SG, Hunt RH. Is there an optimal degree of acid suppression for healing of duodenal ulcers? A model of the relationship between ulcer healing and acid suppression Gastroenterology 1990 99: 345 51.
10. Masahiko I, Jun-ichi T, Hirokazu T, et al. Comparison of the effect on intragastric pH of a single dose of omeprazole or rapeprazole: which is suitable for on-demand therapy? J Gastroenterol Hepatol 2003 18: 1034 8.
11. Nakamura M, Oda M, Akiba Y, et al. Autoradiographic demonstration of lansoprazole uptake sites in rat antrum and colon. J Clin Gastroenterol 1995 20 (Suppl. 2 S8 13.
12. Welage LS. Overview of pharmacologic agents for acid suppression incritically ill patients. Am J Health Syst Pharm 2005 10 (Suppl. 2 S4 10.
13. Kahrilas PJ. Clinical esophageal pH recording: a technical review for practice guideline development. Gastroenterology 1996 110: 1982 96.
14. Aksglaede K, Funch-Jensen P, Thommesen P. Intra-esophageal pH probe movement during eating and talking. Avideoradiographic study. Acta Radiol 2003 44: 131 5.
15. Pandolfino JE, Richter JE, Ours T, et al. Ambulatory esophageal pH monitoring using a wireless system. Am J Gastroenterol 2003 98: 740 9.
16. Fass R, Hell R, Sampliner RE, et al. Effect of ambulatory 24-hour esophageal pH monitoring on reflux-provoking activities. Dig Dis Sci 1999 44: 2263 9.
17. Yamaguchi T. Placement of the Bravo wireless pH monitoring capsule onto the gastric wall under endoscopic guidance. Gastrointest Endosc 2006 63: 1046 50.